Allianz Asset Management »

Travere Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 43k 56.81
2025-12-31 $210k 5.5k 38.21
2022-06-30 $2.7M 110k 24.22
2022-03-31 $1.6M 64k 25.77
2021-12-31 $1.9M 60k 31.05
2021-03-31 $365k 15k 24.94
2020-12-31 $2.3M 84k 27.25